3653 results for «358»
3653 results
Transcatheter mitral valve-in-valve for a patient with a degenerating bioprosthesis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
TAV in TAV for an 8-year old degenerating TAVI device - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
Opening Ceremony - Tokyo Valves 2020
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 opening ceremony, learn more about PCR's mission, charter, companions, and discover what makes this course unique.
Closing Ceremony - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 closing ceremony, and discover who won the best clinical case and best abstract awards this year.
How to optimise PCI in a patient with multivessel disease? LIVE Case
19 Dec 2019 – From GulfPCR-GIM 2019
Watch this case of an 81-year-old female with no prior history of CAD who presented with unstable angina. The patient had recent acute coronary syndrome and baseline angiography shows multivessel disease.
The objectives of this case are:
- Assess your patient as a whole package!
- Lesion preparation is key for...
PCR e-Course 2020: Opening Ceremony - Education & Innovation in Interventional Cardiovascular Medicine
25 Jun 2020 – From PCR e-Course 2020
View the opening ceremony of this brand new digital initiative for the interventional cardiovascular community. Innovation, scientific news and best practice from across the globe!
PCR e-Course 2020 Closing Ceremony: reinventing education in interventional cardiovascular medicine!
28 Jun 2020 – From PCR e-Course 2020
On behalf of the Core Team and the 271 e-Faculty members, Davide Capodanno, Jean Fajadet and William Wijns thank those who attended and participated in - as well as contributed to - PCR e-Course 2020. At a time when exchange with peers and extended networks like...
PCR Valves e-Course 2020: Opening Ceremony
22 Nov 2020 – From PCR Valves e-Course 2020
Get a feel of the positive vibrations at #PCRvalves by watching a recording of the Opening ceremony, which was broadcast live from 3 TV studios in London, Paris and Toulouse! It shares how the comprehensive and innovative 3-day e-Course on the 3 valves – aortic, mitral...
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
